Status:
RECRUITING
Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Conditions:
Breast Diseases
Eligibility:
FEMALE
40-75 years
Brief Summary
500 patients will be prospectively recruited to undergo a fast breast MRI examination. The women will be recruited for the study will meet the following criteria: 1. African American 2. negative DBT e...
Detailed Description
500 patients will be prospectively recruited to undergo an abbreviated or "FAST" breast MRI examination. The women will be recruited for the study must meet the following criteria: 1. African American...
Eligibility Criteria
Inclusion
- African American female
- Negative DBT examination within eleven months prior to recruitment
- Heterogeneoulsy and Extremely breast densities
- Clinically asymptomatic- no palpable masses or focal thickening, etc.
Exclusion
- Patients who are pregnant and lactating
- Patient who have not had a mammogram (DBT) in the past 11months
- Patients who are unwilling or unable to provide written informed consent
- Patients symptomatic for breast disease (e.g. experiencing discharge, lumps, ect.)
- Recent breast surgery in the past 2 years including breast enhancements (e.g. implants or injections)
- Patients who are unable to received an MRI with Gadolinium contrast
- Patients who have not had an MRI of the breast with the past year
Key Trial Info
Start Date :
September 23 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 13 2028
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04854304
Start Date
September 23 2021
End Date
July 13 2028
Last Update
September 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPENN
Philadelphia, Pennsylvania, United States, 19104